Potential of multislice CT in the follow-up of Kawasaki coronary disease.

Hess J. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 2006;107:30–35. 9. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006;17:41–46. 10. Thomas SA, Friedmann E, Kao CW, Inguito P, Metcalf M, Kelley FJ, Gottlieb SS. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006; 15:389–398. 11. Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA 2005; 294:955–958. 12. Santini M, Brachmann J, Cappato R, Davies W, Farre J, Levy S, Quesada A, Ricci RP, Rowland E, Sulke N. Recommendations of the European Cardiac Arrhythmia Society Committee on device failures and complications. Pacing Clin Electrophysiol 2006;29: 653–669. 13. Gornick CC, Hauser RG, Almquist AK, Maron BJ. Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy. Heart Rhythm 2005;2: 681–683. 14. Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calo L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 2004;43: 1494–1499.